-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Neutral on Doximity, Lowers Price Target to $34

Benzinga·02/10/2026 14:02:03
Listen to the news
Mizuho analyst Steven Valiquette maintains Doximity (NYSE:DOCS) with a Neutral and lowers the price target from $45 to $34.